Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2010
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2429308C Novel lactam-substituted pyrazolopyridine derivatives
09/21/2010CA2420568C Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
09/21/2010CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
09/21/2010CA2408746C Antisense phosporodiamidate morpholino oligonucleotide inhibition of cytochrome p450 to modulate drug pharmacokinetics
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2386549C Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one
09/21/2010CA2369292C Method of modulating the activity of functional immune molecules
09/21/2010CA2365890C Method for delivering benzindene prostaglandins by inhalation
09/21/2010CA2306692C Dipeptide apoptosis inhibitors and the use thereof
09/16/2010WO2010104961A1 Treatment methods for autoimmune disorders
09/16/2010WO2010104959A1 Treatment and diagnostic methods for hypersensitive disorders
09/16/2010WO2010104790A2 Fatty-acid based particles
09/16/2010WO2010104563A2 Highly compactable and durable direct compression excipients and excipient systems
09/16/2010WO2010104205A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010WO2010104187A1 Steroid compound
09/16/2010WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010WO2010103845A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103844A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103843A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103429A1 1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists
09/16/2010WO2010103381A1 Spirocyclic piperidine derivatives as trpm 8 modulators
09/16/2010WO2010103312A1 Hydroxymorpholiness and their use for the treatment of inflammatory disorders and pain
09/16/2010WO2010103297A2 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010103283A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010103279A1 Bis aromatic compounds for use as lct4 synthase inhibitors
09/16/2010WO2010103278A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010103130A2 Novel bicyclic heterocycles
09/16/2010WO2010103120A1 New crystals of a benzoylbenzeneacetamide derivative
09/16/2010WO2010103046A1 N-hydroxy c29-amide derivatives of oleandrane
09/16/2010WO2010102958A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases
09/16/2010WO2010102778A2 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
09/16/2010WO2010068520A3 Substituted imidazoheterocycle derivatives
09/16/2010WO2010062900A3 A new family of pain producing substances and methods to produce novel analgesic drugs
09/16/2010WO2010056847A3 Lyophilization formulation
09/16/2010WO2010042212A3 Methods for treating or preventing pain using spicamycin derivatives
09/16/2010WO2010039237A8 Compounds for inflammation and immune-related uses
09/16/2010US20100234784 Interpenetrating network of pva hydrogel cool-compression bandage
09/16/2010US20100234472 Nitric oxide releasing derivatives of paracetamol
09/16/2010US20100234469 New Crystals Of A Benzoylbenzeneacetamide Derivative
09/16/2010US20100234465 Administration of Intravenous Ibuprofen
09/16/2010US20100234462 Topical composition
09/16/2010US20100234449 Immunostimulatory Method
09/16/2010US20100234441 Novel compounds
09/16/2010US20100234429 Substituted nicotinamides as kcnq2/3 modulators
09/16/2010US20100234427 1-phenethylpiperidine derivatives and their use as opioid receptor ligands
09/16/2010US20100234426 Phenylpropionamide Compounds and the Use Thereof
09/16/2010US20100234425 2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors
09/16/2010US20100234421 Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators
09/16/2010US20100234419 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
09/16/2010US20100234404 P-38 Kinase Inhibitors
09/16/2010US20100234397 Enzyme inhibitors
09/16/2010US20100234395 Ureide derivative and pharmaceutical application thereof
09/16/2010US20100234389 Amide compound
09/16/2010US20100234387 Sulfonylated Tetrahydroazolopyrazines and their Use as Pharmaceuticals
09/16/2010US20100234386 Quinoxaline derivatives as pi3 kinase inhibitors
09/16/2010US20100234384 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists
09/16/2010US20100234377 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
09/16/2010US20100234374 Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors
09/16/2010US20100234373 Bis-aryl amide compounds and methods of use
09/16/2010US20100234370 Pharmaceutical compounds
09/16/2010US20100234364 Ccr2 inhibitors and methods of use thereof
09/16/2010US20100234355 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
09/16/2010US20100234345 Novel compounds as cannabinoid receptor ligands
09/16/2010US20100234334 Nitric oxide releasing steroids
09/16/2010US20100234331 Hexahydro-cyclooctyl pyrazole cannabinoid modulators
09/16/2010US20100234328 Antimicrobial Compositions And Related Methods
09/16/2010US20100234324 Quinazolinamide derivatives
09/16/2010US20100234277 Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease
09/16/2010US20100234276 Erythropoietin solution preparation
09/16/2010US20100233294 Use of tellurium compounds for inhibition of interleukin-converting enzyme
09/16/2010US20100233281 Process for decreasing environmental pollutants in an oil or a fat.
09/16/2010US20100233280 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
09/16/2010US20100233279 Compositions And Methods Comprising Analogues Of Radicicol A
09/16/2010US20100233278 Rapidly disintegrating solid preparation
09/16/2010US20100233270 Delivery of Oligonucleotide-Functionalized Nanoparticles
09/16/2010US20100233264 TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF
09/16/2010US20100233232 Fatty-acid based particles
09/16/2010US20100233226 Drug-eluting nanowire array
09/16/2010US20100233186 Novel receptor that binds ctla-8
09/16/2010US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides
09/16/2010US20100233145 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation
09/16/2010US20100233118 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
09/16/2010US20100233083 Microparticles comprising a crosslinked polymer
09/16/2010US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof
09/16/2010DE102009001438A1 New carbonylamino-substituted anilino-pyrimidine compounds are tyrosine kinase-2 inhibitors, useful for treating diseases associated with inflammatory conditions e.g. bronchitis, rheumatoid arthritis, psoriasis and Guillain Barre syndrome
09/16/2010CA2755314A1 New crystals of a benzoylbenzeneacetamide derivative
09/16/2010CA2755120A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010CA2755117A1 Substituted fused pyrimidine compounds
09/16/2010CA2755047A1 Treatment methods for autoimmune disorders
09/16/2010CA2754961A1 Treatment and diagnostic methods for hypersensitive disorders
09/16/2010CA2754946A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010CA2754941A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010CA2754936A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010CA2754934A1 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
09/16/2010CA2754897A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010CA2754781A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010CA2754589A1 Steroid compound
09/16/2010CA2753685A1 Highly compactable and durable direct compression excipients and excipient systems
1 ... 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 ... 1272